Meaningful Use 101. AIRA October 26, 2015

Similar documents
Medicare and Medicaid Programs: Electronic Health Record Incentive Program -- Stage 3 and Modifications to Meaningful Use in 2015 through 2017

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

EHR/Meaningful Use

Oklahoma s Public Health Immunization Reporting Updates. By Brittany Curry of OSDH. An Important Reminder. For audio, you must use your phone:

CMS EHR Incentive Programs in 2015 through 2017 Overview

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet

Final Meaningful Use Objectives for

HIE & Interoperability: Roadmap to Continuum of Care Michael McPherson MU Coordinator KDHE

Meaningful Use and Care Transitions: Managing Change and Improving Quality of Care

Final Meaningful Use Objectives for

Presented by AIRA June 21 st, 2011

Final Meaningful Use Objectives for 2017

Meaningful Use Stage 2

American Recovery & Reinvestment Act

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

CMS Meaningful Use Proposed Rules Overview May 5, 2015

FINAL Meaningful Use Objectives for

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Syndromic Surveillance 2015 Edition CEHRT Promoting Interoperability

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE

Prime Clinical Systems, Inc

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

Meaningful Use Stages 1 & 2

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

Meaningful Use CHCANYS Webinar #1

Meaningful Use - Modified Stage 2. Brett Paepke, OD David Wolfson Marni Anderson

Welcome to the MS State Level Registry Companion Guide for

Eligible Professionals. How can the West Virginia Health Information Network (WVHIN) assist you in meeting Meaningful Use requirements?

Meaningful Use Virtual Office Hours Webinar for Eligible Providers and Hospitals

Proposed Rules for Meaningful Use 1, 2 and 3. Paul Kleeberg, MD, FAAFP, FHIMSS CMIO Stratis Health

2015 Meaningful Use and emipp Updates (for Eligible Professionals)

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

Merit-Based Incentive Payment System (MIPS) Advancing Care Information Performance Category Measure 2018 Performance Period

Stage 1 Changes Tipsheet Last Updated: August, 2012

Measures Reporting for Eligible Providers

Meaningful Use Participation Basics for the Small Provider

HIE Success - Physician Education Series

Challenges for National Large Laboratories to Ensure Implementation of ELR Meaningful Use

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)*

Kentucky HIE Examples of Successful Interoperability Description Template

Recent and Proposed Rule Changes for Meaningful Use

MEANINGFUL USE STAGE 2

Overview of the Changes to the Meaningful Use Program Called for in the Proposed Inpatient Prospective Payment System Rule April 27, 2018

Meaningful Use Stage 2. Physician Office October, 2012

HIE Implications in Meaningful Use Stage 1 Requirements

The History of Meaningful Use

HITECH* Update Meaningful Use Regulations Eligible Professionals

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Updates October 2, 2012 Rick Hoover & Andy Finnegan

Meaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program

during the EHR reporting period.

MEANINGFUL USE FOR THE OB/GYN. Steven L. Zielke, MD 6/13/2014

Meaningful Use and Public Health. Chris Wells Public Health IT Director June 30, 2014

Meaningful Use - Modified Stage Alternate Exclusions and/or Specifications

Transforming Health Care with Health IT

HIE Implications in Meaningful Use Stage 1 Requirements

Game Plan. Meaningful Use Where are We? So is Anyone Registering? So, are EPs getting any money? $31,968,176,183

Meaningful Use 2015 Measures

2015 MU Reporting Overview of Requirements/Tasks

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Pennsylvania ehealth Initiative All Committee Meeting November 14, 2012

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

Meaningful Use Stage 2

Meaningful Use What You Need to Know for December 6, 2016

How to Participate Today 4/28/2015. HealthFusion.com 2015 HealthFusion, Inc. 1. Meaningful Use Stage 3: What the Future Holds

New Hampshire Guidelines for Program Year 2016: Meaningful Use and Clinical Quality Measure Supporting Documents

Meaningful Use Modified Stage 2 Audit Document Eligible Hospitals

Medicaid EHR Incentive Program What You Need to Know about Program Year 2016

ASCs and Meaningful Use. Patrick Doyle, Vice President Sales Jessica McBrayer, RN, Business Analyst Ron Pelletier, Vice President Market Strategy

Legal Issues in Medicare/Medicaid Incentive Programss

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

NEW HAMPSHIRE MEDICAID EHR INCENTIVE PROGRAM

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

Medicaid Provider Incentive Program

Using Telemedicine to Enhance Meaningful Use Qualification

Medical Assistant Credentialing Requirements for Your Client Practices. Eric Christensen Director of Client Services Healthcare Compliance Pros, Inc.

Alaska Medicaid Program

Meaningful Use Update: Stage 3 and Beyond. Carla McCorkle, Midas+ Solutions CQM Product Lead

Overview of the EHR Incentive Program Stage 2 Final Rule

Note: Every encounter type must have at least one value designated under the MU Details frame.

Stage 3 and ACI s Relationship to Medicaid MU Massachusetts Medicaid EHR Incentive Program

HIE/HIO Organizations Supporting Meaningful Use (MU) Stage 2 Goals

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Medicaid EHR Incentive Program Health Information Exchange Objective Stage 3 Updated: February 2017

2016 Requirements for the EHR Incentive Programs: EligibleProfessionals

Overview of the EHR Incentive Program Stage 2 Final Rule published August, 2012

2016 MEANINGFUL USE AND 2017 CHANGES to the Medicare EHR Incentive Program for EPs. September 27, 2016 Kathy Wild, Lisa Sagwitz, and Joe Pinto

CMS Modifications to Meaningful Use in Final Rule. Slide materials and recording will be available after the webinar

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

Copyright All Rights Reserved.

CMS Incentive Programs: Timeline And Reporting Requirements. Webcast Association of Northern California Oncologists May 21, 2013

Texas Medicaid Electronic Health Record (EHR) Incentive Program: Federally Qualified Health Centers (FQHCs)

Medicaid EHR Incentive Program Audits. CMS Multi-Regional Meeting - Regions 1, 2 & 3 September 4, 2014

HIE/HIO Organizations Supporting Meaningful Use (MU) Stage 2 Goals Q Update from 2013 HIE Survey Participants

Relevance of Meaningful Use Requirements for Pathologists and Laboratories Pathology Informatics 2011 October 5, 2011

Maximizing EHR Data for Public Health Reporting. Nedra Garrett, MS Centers for Disease Control & Prevention February 21, 2017

Transcription:

Meaningful Use 101 AIRA October 26, 2015 1

Stage 1 Meaningful Use (Classic) Communicate with public health agencies Objective 1 Ambulatory Measure Hospital Measure Immunization Registries 2 Reportable Lab Results 2 (ELR) Syndromic Surveillance 2 1 test of submission to state immunization registry (unless no registries are capable) with continued submission if successful (y/n) N/A 1 test of submission to public health (unless no ph agency is capable) with continued submission if successful (y/n) 1 test of submission to state immunization registry (unless no registries are capable) with continued submission if successful (y/n) 1 test of submission to public health (unless no ph agency is capable) with continued submission if successful (y/n) 1 test of submission to public health (unless no ph agency is capable) with continued submission if successful (y/n) 1. Unless an EP, eligible hospital or CAH has an exception for all of these objectives and measures they must complete at least one in this group as part of their demonstration of a meaningful use to be eligible for incentives. 2. Public health agencies may specify how to test the data submission and to which specific destination Source: Dr. Paul Kleeberg, Clinical Director, Key Health Alliance 2

Stage 2 Meaningful use (Classic) 3

Mod Rule: Measures for Objective 10 Measure PUBLIC HEALTH AND CLINICAL DATA REGISTRY REPORTING OBJECTIVE Measure 1 Immunization Registry Reporting Measure 2 Syndromic Surveillance Reporting Measure 3 Case Reporting (Dropped) Measure 4 - Public Health Registry Reporting Measure 5 - Clinical Data Registry Reporting (Now Specialized Registries Includes Cancer for EP) Measure 6 - Electronic Reportable Laboratory Results Maximum times measure can count towards objective for EP 1 1 1 1 2 3 n/a 1 Maximum times measure can count towards objective for eligible hospital or CAH 4

Stage 3: Measures for Objective 8 Measure PUBLIC HEALTH AND CLINICAL DATA REGISTRY REPORTING OBJECTIVE Measure 1 Immunization Registry Reporting Measure 2 Syndromic Surveillance Reporting Maximum times measure can count towards objective for EP 1 1 1 1 Measure 3 Case Reporting 1 1 Measure 4 - Public Health Registry Reporting Measure 5 - Clinical Data Registry Reporting Measure 6 - Electronic Reportable Laboratory Results 3 4 3 4 n/a 1 Maximum times measure can count towards objective for eligible hospital or CAH 5

NEW CMS FAQ We do not intend to inadvertently penalize providers for their inability to meet measures that were not required under the previous stages of meaningful use. Nor did we intend to require providers to engage in new activities during 2015, which may not be feasible after the publication of the final rule in order to successfully demonstrate meaningful use in 2015. In the final rule at 80 FR 62788, we discuss our final policy to allow for alternate exclusions and specifications for certain objectives and measures where there is not a Stage 1 measure equivalent to the Modified Stage 2 (2015 through 2017) measure or where a menu measure is now a requirement. This includes the public health reporting objective as follows. First, EPs scheduled to be in Stage 1 may attest to only 1 public health measure instead of 2 and eligible hospitals or CAHs may attest to only 2 public health measures instead of 3. Second, we will allow providers to claim an alternate exclusion for a measure if they did not intend to attest to the equivalent prior menu objective consistent with our policy for other objectives and measures as described at 80 FR 62788. We will allow Alternate Exclusions for the Public Health Reporting Objective in 2015 as follows: EPs scheduled to be in Stage 1: Must attest to at least 1 measure from the Public Health Reporting Objective Measures 1-3 May claim an Alternate Exclusion for Measure 1, Measure 2 or Measure 3. An Alternate Exclusion may only be claimed for up to two measures, then the provider must either attest to or meet the exclusion requirements for the remaining measure described in 495.22 (e)(10)(i)(c). EPs scheduled to be in Stage 2: Must attest to at least 2 measures from the Public Health Reporting Objective Measures 1-3 May claim an Alternate Exclusion for Measure 2 or Measure 3 (Syndromic Surveillance Measure or Specialized Registry Reporting Measure) Eligible hospitals/cahs scheduled to be in Stage 1: Must attest to at least 2 measures from the Public Health Reporting Objective Measures 1-4 May claim an Alternate Exclusion for Measure 1, Measure 2, Measure 3 or Measure 4 An Alternate Exclusion may only be claimed for up to three measures, then the provider must either attest to or meet the exclusion requirements for the remaining measure described in 495.22 (e)(10)(ii)(c). Eligible hospitals/cahs scheduled to be in Stage 2: Must attest to at least 3 measures from the Public Health Reporting Objective Measures 1-4 May claim an Alternate Exclusion for Measure 3 (Specialized Registry Reporting Measure) 6

Meaningful Use Technical Assistance

Meaningful Use Public Health Technical Assistance Team Assist in resolving issues and problems preventing successful achievement of the Meaningful Use public health objectives Provide focused policy and technical expertise Identify successful methods used to resolve similar issues Rapidly resolve misunderstandings and simple problems Document and learn from the real problems occurring the field Note issues may originate with providers, EHR vendors, public health jurisdictions or other stakeholders 8 Office of Surveillance, Epidemiology, and Laboratory Services Division of Informatics Practice, Policy & Coordination

MU Technical Assistance Team MU PH Related Issues / Problems / Requests from Multiple Sources #1) Issue / Request Review & On-Boarding Process Review issue / request Clarify issue / request with originator (if necessary) Either: 1) Accept, prioritize and queue issue/request or 2) Redirect or reject issue / request Team Lead (with support from Primary Team and Support Team Resources) Issue / Request Documentation & Tracking #3) Control and Reporting Assign SMEs Status reporting Manage SME time utilization Accepted Issue / Request Queue #2) Issue / Request Resolution Process Initial analysis & research Contact PH agency offer services, if accepted Perform necessary research and attempt to facilitate resolution (iterative) Reach acceptable resolution or work period expires Complete documentation Primary Team (with support from Support Team Resources and Team Lead) 9 Office of Surveillance, Epidemiology, and Laboratory Services Public Health Informatics and Technology Program Office

MU Technical Assistance Team sample issues resolved EP using a vendor s product was not populating Provider ID information in the immunization message which was not acceptable to the immunization registry. Facilitated discussion between the state DOH, registry, and vendor resulting in an interim solution for testing and vendor s commitment to address issue in the next release of the product. State DOHs challenged to support MU testing and on-boarding of providers / hospital to initiate data submission. Suggested use of Registration of Intent to allow providers to meet measure while DOH prioritized providers Hospital missing certified technology module necessary to submit data to PH. Facilitated discussion between hospital, state DOH, REC, and HIE to identify an option for the hospital to use certified technology available through the HIE to submit data to PH. 10 Office of Surveillance, Epidemiology, and Laboratory Services Division of Informatics Practice, Policy & Coordination

MU Technical Assistance Team To request technical assistance from the MU PH TA team, send an email to the CDC Meaningful Use Mailbox (meaningfuluse@cdc.gov) with Request for Technical Assistance in the Subject line. Please include a detailed description of the issue or problem and your contact information. 11 Office of Surveillance, Epidemiology, and Laboratory Services Division of Informatics Practice, Policy & Coordination

Active Engagement

Stage 2 Onboarding Process 13

Declaration of Readiness Declare on your own website capacity to accept data Detailed types of providers, size, etc Avoid requests for letters of exclusion Note providers to use website for audit documentation Mod rule/stage 3: six months prior to start of reporting period Note CMS Repository may be future requirement 14

Registration of Intent PHAs must have a process and/or system established to accept provider registrations Determine what information the PHA should capture during registration Method for provider to confirm registration was successful (Provider s documentation for pre-payment attestation) Only need to register once; registration from previous years carry over if they have not moved into production 15

Onboarding PHAs will onboard Providers that register their intent to submit data for the MU objectives. Separate onboarding is required for each MU objective. PHA prioritize Providers that register PHA invites Provider to begin testing and validation PHA and Provider engage in data testing and validation After successful testing and validation Provider initiates ongoing submission 16

Onboarding EP/EH Uses CMS Centralized Repository 30 day response now applies to Production issue with Mod Rule and Stage 3 EP/EH Attests to Meeting Measure Exclusion No Is PH Capable? Yes Yes MU Measure Met? No (Registration of Intent) EP/EH Registration of Intent with PH (Acknowledgement) PH Provides EP/EH Acknowledgement PH Requests EP/EH Action (Written Requests) EP/EH Takes Action? No EP/EH Achieves On-Going Submission Yes 1st Time Failure to Respond? No Failure (On-Boarding) 17

Acknowledgement PHAs provide written communications affirming Providers are able to submit relevant public health data to the PHA (Provider achieved ongoing submission). The Providers use this written communication to support their attestation. Examples of written communications include, but are not limited to: Email sent to provider Letter mailed to provider HL7 Acknowledgement Messages from Immunization/Syndromic submissions Posting information on PHA website Provide at end of calendar year for audit purposes for provider Date registered Dates requests for action sent (onboarding/production) Dates requests resolved 18

Jurisdictional Variation for Public Health Measures

What does CEHRT mean? ONC develops test procedures for each PH Measure Testing done by certified test labs Scenarios for each public health measure Test data Expected outcome Give EHR Test data/look for appropriate results Based on referenced IG Tests only R and RE fields (not O) 20

Interoperability Status Check NIST Test messages consumed by jurisdictional registry (n=30) 9 jurisdictions passed messages 21 jurisdictions returned errors 8 have major issues that need to be addressed 12/15/2016 Office of the National Coordinator for Health Information Technology 21

Types of Errors: Non-issues Ex: Address field treated as R instead of RE Vendor product certified for function Training on provider use of certified HER Provider should have address Does not violate HL7 Guide Action: No needed action 12/15/2016 Office of the National Coordinator for Health Information Technology 22

Types of Errors: Major Issues Ex: Dose amount recorded incorrectly Should be amount (numeric) and units (text) in separate fields; some jurisdictions asking for number of adult doses vs. number of pediatric doses Certified product would not have capacity Violates HL7 Guide Action: jurisdiction should make changes to receiving system 12/15/2016 Office of the National Coordinator for Health Information Technology 23

Types of Errors: Legitimate Business Need Ex: Insurance information: R instead of O Vendor product not certified for function Jurisdiction requires in order to charge insurance for doses administered Does not violate HL7 Guide Action: Ensure these issues still follow HL7 Guide 12/15/2016 Office of the National Coordinator for Health Information Technology 24

Strategy (Longer term) Update HL7 Implementation Guide Could address issues like insurance (change from O to RE) Consider interim certification criteria based on updated IG Standardize SOAP WSDL Usage 12/15/2016 Office of the National Coordinator for Health Information Technology 25

ONC/CDC Pilots Cross Jurisdictional Data Exchange and Consumer Access to IIS

Background & Context Current IIS Data Exchange Limited exchange across jurisdictions This exchange is currently done point-to-point; mainly batch files; not real time ONC Initiative Pilot states will transfer data via a data hub with partner jurisdictions Pilot states will use an adapted version of the CDC Web Services Definition Language (WSDL) Pilot states will use the HL7 Immunization Implementation Guide V1.5 (HL7 2.5.1 IZ IG V1.5) Future? All IIS will interface with the hub and exchange data will all other IIS All IIS will use the adapted CDC WSDL and HL7 IZ IG V1.5 Advantage of HUBsolution: Promotes use of adapted CDC WSDL and HL7 IZ IG V1.5 which will drive interoperability Will improve use of bidirectional querying by IIS Scalable solution More IIS can easily be added to the hub IIS will be able to theoretically communicate with any other IIS on the hub

IIS Data Exchange Use Case Diagram Use Case Objective: For an Immunization Information System (IIS) to respond to a transaction that contains current or historical addresses that are outside its jurisdiction by triggering a QBP or VXU to the other jurisdiction s IIS. Actors Entry Points IIS Hub (Additional IIS ) 1 Provider 4 2 Provider EHR system Virginia IIS Central Data Hub Maryland IIS 3 Consumer Patient Portal DC IIS

Consumer Access to IIS Five pilot states Consumer portal communicates with IIS Bi-directional standards Policy Issues Provider Education Patient Authentication Marketing as well as technology solution

Questions? James.Daniel@hhs.gov Follow me @jim_daniel (Note Twitter Followers receive email responses on average 24 hours faster)